Comprehensive Analysis of Clinicopathologic Factors Predictive of an Unfavorable Prognosis in Patients With Acinic Cell Carcinoma of the Parotid Gland
- PMID: 32392906
- PMCID: PMC7904441
- DOI: 10.21053/ceo.2019.01550
Comprehensive Analysis of Clinicopathologic Factors Predictive of an Unfavorable Prognosis in Patients With Acinic Cell Carcinoma of the Parotid Gland
Abstract
Objectives: In subset of patients, acinic cell carcinoma (AcCC) exhibits aggressive features such as recurrence, distant metastasis, and mortality. This study aimed to investigate clinicopathologic factors influencing patients' prognosis and to identify adverse features predictive of an unfavorable prognosis.
Methods: Between January 2000 and December 2016, 59 patients with AcCC were enrolled in this study.
Results: The patients' 5-year overall survival rate was 93.3%, and their 5-year recurrence-free survival rate was 80.5%. During the study period, recurrence occurred in 10 patients. The mean time to recurrence after surgery was 26 months (range, 5-60 months). During the study period, three patients died from the disease. Univariate analysis showed that sex, surgical extent, extranodal extension, T classification, and TNM stage were significantly associated with disease recurrence. Multivariate analysis showed that, among the clinicopathologic factors included in the analysis, only TNM stage displayed a statistically significant correlation with disease recurrence.
Conclusion: Surgical treatment alone yielded good results for AcCC, and additional treatment did not affect the recurrence-free survival rate or the overall survival rate, even when the resection margin was less than 1 mm. Other pathologic factors did not show prognostic significance for disease recurrence or death.
Keywords: Acinic Cell Carcinoma; Parotid Gland; Prognostic Factor.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures




Similar articles
-
Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland.JAMA Otolaryngol Head Neck Surg. 2018 Nov 1;144(11):1011-1016. doi: 10.1001/jamaoto.2018.0788. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29978180 Free PMC article.
-
Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience.Otolaryngol Head Neck Surg. 2015 Dec;153(6):981-9. doi: 10.1177/0194599815594789. Epub 2015 Jul 22. Otolaryngol Head Neck Surg. 2015. PMID: 26203086
-
Surgery Alone Is Effective in the Management of Pediatric Salivary Gland Acinic Cell Carcinoma.J Oral Maxillofac Surg. 2019 Aug;77(8):1713-1723. doi: 10.1016/j.joms.2019.01.044. Epub 2019 Feb 5. J Oral Maxillofac Surg. 2019. PMID: 30825434
-
Prognostic Factors Associated With Decreased Survival in Patients With Acinic Cell Carcinoma of the Parotid Gland.J Oral Maxillofac Surg. 2017 Feb;75(2):416-422. doi: 10.1016/j.joms.2016.06.185. Epub 2016 Jul 1. J Oral Maxillofac Surg. 2017. PMID: 27474461
-
Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.Urology. 2004 Oct;64(4):744-8. doi: 10.1016/j.urology.2004.05.003. Urology. 2004. PMID: 15491713 Review.
Cited by
-
Acinic Cell Carcinoma in the 21st Century: A Population-Based Study from the SEER Database and Review of Recent Molecular Genetic Advances.Cancers (Basel). 2023 Jun 27;15(13):3373. doi: 10.3390/cancers15133373. Cancers (Basel). 2023. PMID: 37444484 Free PMC article.
-
A Retrospective Multicenter Italian Analysis of Epidemiological, Clinical and Histopathological Features in a Sample of Patients with Acinic Cell Carcinoma of the Parotid Gland.Cancers (Basel). 2023 Nov 17;15(22):5456. doi: 10.3390/cancers15225456. Cancers (Basel). 2023. PMID: 38001716 Free PMC article.
-
Acinic cell carcinoma of the parotid gland: Timeo Danaos et dona ferentes? A multicenter retrospective analysis focusing on survival outcome.Eur Arch Otorhinolaryngol. 2022 Dec;279(12):5821-5829. doi: 10.1007/s00405-022-07481-w. Epub 2022 Jun 9. Eur Arch Otorhinolaryngol. 2022. PMID: 35678874 Free PMC article.
-
Head and Neck Acinic Cell Carcinoma: A New Grading System Proposal and Diagnostic Utility of NR4A3 Immunohistochemistry.Am J Surg Pathol. 2022 Jul 1;46(7):933-941. doi: 10.1097/PAS.0000000000001867. Epub 2022 Jan 17. Am J Surg Pathol. 2022. PMID: 35034042 Free PMC article.
References
-
- Patel NR, Sanghvi S, Khan MN, Husain Q, Baredes S, Eloy JA. Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases. Laryngoscope. 2014 Jan;124(1):172–8. - PubMed
-
- Gomez DR, Katabi N, Zhung J, Wolden SL, Zelefsky MJ, Kraus DH, et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer. 2009 May;115(10):2128–37. - PubMed
-
- Biron VL, Lentsch EJ, Gerry DR, Bewley AF. Factors influencing survival in acinic cell carcinoma: a retrospective survival analysis of 2061 patients. Head Neck. 2015 Jun;37(6):870–7. - PubMed
-
- Cho JK, Lim BW, Kim EH, Ko YH, Oh D, Noh JM, et al. Low-grade salivary gland cancers: treatment outcomes, extent of surgery and indications for postoperative adjuvant radiation therapy. Ann Surg Oncol. 2016 Dec;23(13):4368–75. - PubMed
-
- Richter SM, Friedmann P, Mourad WF, Hu KS, Persky MS, Harrison LB. Postoperative radiation therapy for small, low-/intermediate-grade parotid tumors with close and/or positive surgical margins. Head Neck. 2012 Jul;34(7):953–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources